肥胖的进食行为神经生物学:机制与治疗靶点:第 23 届哈佛营养肥胖研讨会报告。
The Neurobiology of Eating Behavior in Obesity: Mechanisms and Therapeutic Targets: A Report from the 23rd Annual Harvard Nutrition Obesity Symposium.
机构信息
Division of Pediatric Endocrinology, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA, United States.
Metabolism Unit, Massachusetts General Hospital, Boston, MA, United States; Nutrition Obesity Research Center at Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States.
出版信息
Am J Clin Nutr. 2023 Jul;118(1):314-328. doi: 10.1016/j.ajcnut.2023.05.003. Epub 2023 May 4.
Obesity is increasing at an alarming rate. The effectiveness of currently available strategies for the treatment of obesity (including pharmacologic, surgical, and behavioral interventions) is limited. Understanding the neurobiology of appetite and the important drivers of energy intake (EI) can lead to the development of more effective strategies for the prevention and treatment of obesity. Appetite regulation is complex and is influenced by genetic, social, and environmental factors. It is intricately regulated by a complex interplay of endocrine, gastrointestinal, and neural systems. Hormonal and neural signals generated in response to the energy state of the organism and the quality of food eaten are communicated by paracrine, endocrine, and gastrointestinal signals to the nervous system. The central nervous system integrates homeostatic and hedonic signals to regulate appetite. Although there has been an enormous amount of research over many decades regarding the regulation of EI and body weight, research is only now yielding potentially effective treatment strategies for obesity. The purpose of this article is to summarize the key findings presented in June 2022 at the 23rd annual Harvard Nutrition Obesity Symposium entitled "The Neurobiology of Eating Behavior in Obesity: Mechanisms and Therapeutic Targets." Findings presented at the symposium, sponsored by NIH P30 Nutrition Obesity Research Center at Harvard, enhance our current understanding of appetite biology, including innovative techniques used to assess and systematically manipulate critical hedonic processes, which will shape future research and the development of therapeutics for obesity prevention and treatment.
肥胖率正在以惊人的速度增长。目前用于治疗肥胖的策略(包括药物、手术和行为干预)效果有限。了解食欲的神经生物学和能量摄入的重要驱动因素,可以为预防和治疗肥胖症开发更有效的策略。食欲调节是复杂的,受遗传、社会和环境因素的影响。它受到内分泌、胃肠道和神经系统之间复杂的相互作用的精细调节。机体能量状态和所吃食物质量产生的激素和神经信号通过旁分泌、内分泌和胃肠信号传递到神经系统。中枢神经系统整合稳态和享乐信号来调节食欲。尽管几十年来,人们对能量摄入和体重的调节进行了大量的研究,但目前的研究才为肥胖症的治疗提供了潜在有效的策略。本文的目的是总结 2022 年 6 月在第 23 届年度哈佛营养肥胖研讨会(题为“肥胖症饮食行为的神经生物学:机制和治疗靶点”)上提出的关键发现。由美国国立卫生研究院 P30 营养肥胖研究中心赞助的研讨会提出的发现,增强了我们对食欲生物学的现有认识,包括用于评估和系统地操纵关键享乐过程的创新技术,这将塑造未来肥胖预防和治疗的研究和治疗方法的发展。
相似文献
Neuropharmacology. 2012-1-30
J Neuroendocrinol. 2010-6-9
Proc Nutr Soc. 2012-7-17
Int J Obes (Lond). 2009-6
Gastroenterology. 2017-5
引用本文的文献
Nat Rev Gastroenterol Hepatol. 2024-5
本文引用的文献
Cell. 2022-7-7
N Engl J Med. 2022-7-21
Neurobiol Stress. 2021-12-28
Transl Psychiatry. 2022-1-10
Mol Metab. 2022-3